Publications for Staffan Hägg
Co-author map based on ISI articles 2007-
Publications mentioned in social media 24 times*
Journal Articles
Johanna Strandell, Niklas G Noren and Staffan Hägg
Key Elements in Adverse Drug Interaction Safety Signals An Assessment of Individual Case Safety Reports
Drug Safety, 2013, 36(1), 63-70.
|
Ida Hallbäck, Staffan Hägg, Andreas Eriksson and Per Whiss
In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation
Pharmacological Reports, 2012, 64(4), 979-983.
|
Katja Hakkarinen, Sten Olsson and Staffan Hägg
The scale and nature of adverse events in hospital – Is an event drug-related?
BMJ. British Medical Journal, 2012, , .
|
Henrik Lövborg, Anna K Jönsson and Staffan Hägg
A fatal outcome after unintentional overdosing of rivastigmine patches
Current drug safety, 2012, 7(1), 30-2.
Fulltext  |
Anna K. Jönsson, Olav Spigset and Staffan Hägg
Venous Thromboembolism in Recipients of Antipsychotics: Incidence, Mechanisms and Management
CNS Drugs, 2012, 26(8), 649-662.
|
Hanna Gyllensten, Katja M. Hakkarainen, Anna K. Jonsson, Karolina Andersson Sundell, Staffan Hägg, Clas Rehnberg and Anders Carlsten
Modelling drug-related morbidity in Sweden using an expert panel of pharmacists
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34(4), 538-546.
|
Henrik Lövborg, Linda Ring Eriksson, Anna K Jonsson, Thomas Bradley and Staffan Hägg
A prospective analysis of the preventability of adverse drug reactions reported in Sweden
European Journal of Clinical Pharmacology, 2012, 68(8), 1183-1189.
Fulltext |
Katja M Hakkarainen, Khadidja Hedna, Max Petzold and Staffan Hägg
Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions - a meta-analysis
PloS one, 2012, 7(3), e33236.
Fulltext Web of Science® Times Cited: 5 |
Katja M Hakkarainen, Daniel Alström, Staffan Hägg, Anders Carlsten and Hanna Gyllensten
Modelling drug-related morbidity in Sweden using an expert panel of physicians
European Journal of Clinical Pharmacology, 2012, 68(9), 1309-1319.
Fulltext Web of Science® Times Cited: 1 |
Katja Marja Hakkarainen, Karolina Andersson Sundell, Max Petzold and Staffan Hägg
Methods for assessing the preventability of adverse drug events: A systematic review
Drug Safety, 2012, 35(2), 105-26.
Fulltext Web of Science® Times Cited: 4 |
Marie-Louise Johansson, Staffan Hägg and Susanna M Wallerstedt
Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled stud.
BMC clinical pharmacology, 2011, 11(14), .
|
Ingrid A L Persson, Karin Persson, Staffan Hägg and Rolf G G Andersson
Effects of cocoa extract and dark chocolate on angiotensin-converting enzyme and nitric oxide in human endothelial cells and healthy volunteers--a nutrigenomics perspective.
Journal of Cardiovascular Pharmacology, 2011, 57(1), 44-50.
Web of Science® Times Cited: 8 |
Ingrid A-L Persson, Karin Persson, Staffan Hägg and Rolf G G Andersson
Effects of green tea, black tea and Rooibos tea on angiotensin-converting enzyme and nitric oxide in healthy volunteers
Public Health Nutrition, 2010, 13(5), 730-737.
Web of Science® Times Cited: 11 |
Elisabet Ekman, Staffan Hägg, Anders Sundström and Viktoria Werkström
Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers
Drug, Healthcare and Patient Safety, 2010, 2, 21-25.
|
Anna Jönsson and Staffan Hägg
Många läkemedelsorsakade dödsfall kan förhindras
Läkartidningen, 2010, 107(11), 745.
|
Stergios Kechagias, Staffan Hägg and Kourosh Lofti
Läkemedelsorsakad leverskada av kosttillskottet Fortodol: Manipulerat preparat försenade diagnos
Läkartidningen, 2010, 107(4), 186-188.
|
Anna K. Jönsson, Katja M. Hakkarainen, Olav Spigset, Henrik Druid, Anne Hiselius and Staffan Hägg
Preventable drug related mortality in a Swedish population
Pharmacoepidemiology and Drug Safety, 2010, 19(2), 211-215.
Web of Science® Times Cited: 5 |
John Karlsson, Susanna M Wallerstedt, Kristina Star, Andrew Bate and Staffan Hägg
Letter: Sudden Cardiac Death in Users of Second-Generation Antipsychotics
Journal of Clinical Psychiatry, 2009, 70(12), 1725-1726.
Web of Science® Times Cited: 1 |
H. Lovborg, I. Jacobsson and Staffan Hägg
Hostmedicin förstärkte effekten av warfarin: Cocillana-Etyfin höjde PK(INR)-värdet
Läkartidningen, 2009, 106(45), 2968-2969.
|
Micaela Tjäderborn, Anna K Jönsson, Johan Ahlner and Staffan Hägg
Tramadol dependence: a survey of spontaneously reported cases in Sweden.
Pharmacoepidemiology and drug safety, 2009, , .
Web of Science® Times Cited: 8 |
Ingela Jacobsson, Anna K Jönsson, Barbro Gerdén and Staffan Hägg
Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden.
Pharmacoepidemiology and drug safety, 2009, , .
Web of Science® Times Cited: 16 |
Anna Jonsson, Olav Spigset, Micaela Tjäderborn, Henrik Druid and Staffan Hägg
Fatal drug poisonings in a Swedish general population.
BMC clinical pharmacology, 2009, 9(7), 1-5.
Fulltext |
Anna K. Jönsson, Erzsebet Horváth-Puhó, Staffan Hägg, Lars Pedersen and Henrik T Sörensen
Antipsychotics and risk for venous thromboembolism: A population based case-control study
Clinical Epidemiology, 2009, 1, 19-26.
Fulltext |
Robert Kronstrand, Ingrid Nyström, Malin Andersson, Lina Gunnarsson, Staffan Hägg, Martin Josefsson and Johan Ahlner
Urinary Detection Times and Metabolites/Parent Compound ratios After a Single Dose of Buprenorphine
Journal of Analytical Toxicology, 2008, 32(8), 586-593.
|
Staffan Hägg, Andrew Bate, Malin Stahl and Olav Spigset
Associations between venous thromboembolism and antipsychotics: A study of the WHO database of adverse drug reactions
Drug Safety, 2008, 31(8), 685-694.
|
Anna Jönsson, Lars Brudin, Johan Ahlner, Karin Hedenmalm, Anders Eriksson and Staffan Hägg
Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series.
International Clinical Psychopharmacology, 2008, 23(5), 263-268.
|
Cecilia Åström-Lilja, Johanna Mercke Odeberg, Elisbet Ekman and Staffan Hägg
Drug-induced torsades de pointes: A review of the Swedish pharmacovigilance database
Pharmacoepidemiology and Drug Safety, 2008, 17(6), 587-592.
Web of Science® Times Cited: 15 |
Maria Dolores Cherma Yeste, Margareta Reis, Staffan Hägg, Johan Ahlner and Finn Bengtsson
Therapeutic Drug Monitoring of Ziprasidone in a Clinical Treatment Setting
Therapeutic Drug Monitoring, 2008, 30(6), 682-688.
|
Karin Wester, Anna Jönsson, Olav Spigset and Staffan Hägg
Spontaneously reported fatal suspected adverse drug reactions: A 10-year survey from Sweden
Pharmacoepidemiology and Drug Safety, 2007, 16(2), 173-180.
Web of Science® Times Cited: 9 |
Stina Axelsson Rosén, Staffan Hägg, Andreas Eriksson, Tomas Lindahl and Per A Whiss
In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation
Clinical and experimental pharmacology & physiology, 2007, 34(8), 775-780.
Web of Science® Times Cited: 24 |
Roland Lennestål, Cay Asplund, Mats Nilsson, Hans-Åke Lakso, Tom Mjörndal and Staffan Hägg
Serum levels of olanzapine in a non-fatal overdose
Journal of Analytical Toxicology, 2007, 31(2), 119-121.
Web of Science® Times Cited: 5 |
Micaela Tjäderborn, Anna Jönsson, Staffan Hägg and Johan Ahlner
Fatal unintentional intoxications with tramadol during 1995-2005
Forensic Science International, 2007, 173(2-3), 107-111.
Web of Science® Times Cited: 11 |
Anna K. Jönsson, Olav Spigset, Ingela Jacobsson and Staffan Hägg
Cerebral haemorrhage induced by warfarin - the influence of drug-drug interactions
Pharmacoepidemiology and drug safety, 2007, 16(3), 309-315.
Web of Science® Times Cited: 13 |
Karin Wester, Anna K. Jönsson, Olav Spigset, Henrik Druid and Staffan Hägg
Incidence of fatal adverse drug reactions: A population based study
British Journal of Clinical Pharmacology, 2007, 65(4), 573-579.
Web of Science® Times Cited: 48 |
Staffan Hägg, Y Lindblom, Tom Mjörndal and R Adolfsson
High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia
International Clinical Psychopharmacology, 2006, 21(2), 93-98.
Web of Science® Times Cited: 61 |
Anna Jönsson, Ingela Jacobsson, Mats Andersson and Staffan Hägg
Stor underrapportering av hjärnblödning som läkemedelsbiverkning
Läkartidningen, 2006, 103, 3456-3458.
|
E Samuelsson and Staffan Hägg
Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users
Acta Obstetricia et Gynecologica Scandinavica, 2004, 83(7), 674-681.
Web of Science® Times Cited: 20 |
O Spigset and Staffan Hägg
Nya antidepressiva under graviditet och amning
Läkartidningen, 2004, 101 13, 1176-1181.
|
Conference Articles
H Gyllensten, K M Hakkarainen, A K Jönsson, K Andersson Sundell, Staffan Hägg, C Rehnberg and A Carlsten
DRUG-RELATED MORBIDITY - MODELING THE COST-OF-ILLNESS IN SWEDEN USING PHARMACISTS OPINION in VALUE IN HEALTH, vol 14, issue 7, pp A344-A344
VALUE IN HEALTH, 2011.
|
J Strandell, G N Noren and Staffan Hägg
Key Elements Contributing to Adverse Drug Interaction Safety Signals in DRUG SAFETY, vol 34, issue 10, pp 1004-1005
DRUG SAFETY, 2011.
|
Linda Ring Eriksson, Staffan Hägg, Henrik Lövborg and Thomas Bradley
Drug Related Morbidity among Patients with Complex Health Care Needs Visiting an Emergency Room - A Pilot Study in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol 20, issue , pp S330-S331
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011.
|
Katja M Hakkarainen, Khadidja Hedna, Max Petzold and Staffan Hägg
Frequency of Preventable Adverse Drug Reactions in Outpatients and Inpatients and Their Preventability A Meta-Analysis in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol 20, issue , pp S353-S353
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011.
|
J. Strandell, G.N. Noren and Staffan Hägg
REPORTED INFORMATION CONTRIBUTING TO ADVERSE DRUG INTERACTION SAFETY SIGNALS in BASIC and CLINICAL PHARMACOLOGY and TOXICOLOGY, vol 109, issue , pp 84-84
BASIC and CLINICAL PHARMACOLOGY and TOXICOLOGY, 2011.
|
G Khodabakhshi, K Star, G N Noren and Staffan Hägg
Variations Across Drug Classes in Reported Time-to-Onset of Suspected Adverse Drug Reactions in DRUG SAFETY, vol 33, issue 10, pp 926-926
DRUG SAFETY, 2010.
|
Marie-Louise Johansson, Gertrud Brunlof, Staffan Hägg and Susanna M Wallerstedt
Effects of a One Page ADR Information Letter on the Reporting Rate and the Information Value of ADR Reports
in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol 18, 2009.
|
Ingrid Persson, Karin Persson, Staffan Hägg and Rolf Andersson
Effects of green tea, black tea and rooibos on angiotensin-converting enzyme activity in healthy volunteers
in Planta Medica(ISSN 0032-0943), 2009.
|
Micaela Tjäderborn, Anna Jönsson, Johan Ahlner and Staffan Hägg
Tramadol Dependence: A Survey of Spontaneously Reported Cases in Sweden
24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2008.
|
Ingela Jacobsson, M Danell Boman, Anna Jönsson and Staffan Hägg
Who Reports Suspected Adverse Drug Reactions to the Spontaneous Reporting System in Sweden?
24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2008.
|
Micaela Tjäderborn, Anna Jönsson, Johan Ahlner and Staffan Hägg
Tramadolberoende: En studie av spontanrapporterade fall i Sverige 1995-2006
Läkarstämman, Göteborg, 2008.
|
John Karlsson, Staffan Hägg, Kristina Star and Susanna M Wallerstedt
Plötslig död och behandling med andra generationens antispykotika: Data från WHO:s Biverkningsdatabas (Vigibase)
Läkarstämman, Göteborg, 2008.
|
Anna Jönsson, Ingela Jacobsson, Karolina Andersson, Staffan Hägg and Anders Sundström
Factors Predisposing an Abstract To Be Accepted for Oral Presentation
Pharmacoepidemiology and drug safety, 2008.
|
John Karlsson, Staffan Hägg, Kristina Star and Susanna M Wallerstedt
Sudden Death and Treatmet with New Generation Antipsychotics: Data from the WHO Database of Adverse Drug Reactions (Vigibase)
Pharmacoepidemiology and drug safety, 2008.
|
Anna Jönsson, Lars Brudin, Johan Ahlner, Karin Hedenmalm, Anders Eriksson and Staffan Hägg
Antispychotics Associated with Pulmonary Emboi in a Swedish Medico-Legal Autopsy Series
Joint meeting of the TIAFT and ICADTS and featuring the 8th Ignition Interloc Symposium, 2007.
|
Anna Jönsson, Henrik Sörensen, Erzébet Horváth-Puhó and Staffan Hägg
Association between Venous Thromboembolism and Antipsychotics: A Population Based Case-Control Study
Pharmacoepidemiology and Drug Safety, 2007.
|
Ingela Jacobsson, Anna Jönsson, Barbro Gerdén, Cecilia Axling and Staffan Hägg
Spontaneously Reported Suspected Adverse Drug Reactions in Association with Complementary and Alternative Medicine Products
Pharmacoepidemiology and Drug Safety, 2007.
|
Karin Wester, Anna Jönsson and Staffan Hägg
Incidence of Suspected Drug-Related Deaths in a Swedish Population
Pharmacoepidemiology and drug safety, 2007.
|
Karin Wester, Anna Jönsson, Olav Spigset, Henrik Druid and Staffan Hägg
Incidens av läkemedelsrelaterad dödslighet i Sverige
Läkarsällskapets Riksstämma,2007, 2007.
|
Olav Spigset, Andrew Bate, Malin Ståhl and Staffan Hägg
Venous thromboembolism during treatment with antipsychotics
22nd International Conference on Pharmacoepidemiology Therapeutic Risk Management,2006, 2006.
|
Anna Jönsson, Lars Brundin, Johan Ahlner, Karin Hedenmalm, Anders Eriksson and Staffan Hägg
Low-potency and atypical antipsychotics were associated with pulmonary embolism among Swedish autopsy cases
International conference on Pharmacoepidemiology Therapeutic risk management,2006, 2006.
|
Karin Wester, Anna Jönsson, Olav Spigset and Staffan Hägg
Spontaneously reported fatal adverse drug reactions: a 10-year survey from Sweden
International conference on Pharmacoepdemiology Therapeutic risk management,2006, 2006.
|
Anna Jönsson, Mats Andersson, Ingela Jacobsson and Staffan Hägg
Stor underrapportering av hjärnblödningar under warfarinbehandling
Läkarsällskapets Riksstämma,2005, 2005.
|
Karin Wester, Anna Jönsson and Staffan Hägg
Fatala läkemedelsbiverkningar - spontanrapporterade fall i Sverige 1995 - 2004
Läkarsällskapets Riksstämma,2005, 2005.
|
Anna Jönsson, Mats Andersson, Ingela Jacobsson and Staffan Hägg
Large underreporting of cerebral haemorrhage during warfarin treatment in Sweden
7th Congress of European association for clinical pharmacology,2005, 2005.
|
Ph.D. Theses
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.
Ph.D., Lic. Theses
